Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region

Emmenegger M. et al, (2023), iScience, 26, 105928 - 105928

VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein Display.

Kingston NJ. et al, (2023), mSphere

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Liew F. et al, (2023), eBioMedicine, 87, 104402 - 104402

Publisher Correction: A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.

Bahar MW. et al, (2022), Commun Biol, 5

A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75.

Huo J. et al, (2022), Cell reports

A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.

Bahar MW. et al, (2022), Commun Biol, 5

Switching of Receptor Binding Poses between Closely Related Enteroviruses

Zhou D. et al, (2022), Viruses, 14, 2625 - 2625

Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6.

Dijokaite-Guraliuc A. et al, (2022), Cell discovery, 8

Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum.

Huo J. et al, (2022), Cell discovery, 8

Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study

Vink E. et al, (2022), Open Forum Infectious Diseases, 9

Cryo‐EM structures of perforin‐2 in isolation and assembled on a membrane suggest a mechanism for pore formation

Yu X. et al, (2022), The EMBO Journal

Production and Characterisation of Stabilised PV-3 Virus-like Particles Using Pichia pastoris.

Sherry L. et al, (2022), Viruses, 14

Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.

Siggins MK. et al, (2022), Immunology

Perforin-2 clockwise hand-over-hand pre-pore to pore transition mechanism.

Jiao F. et al, (2022), Nature communications, 13

Single molecule tracking the uncoupling of assembly and membrane insertion in Perfringolysin O.

Senior MJT. et al, (2022), The FEBS journal

Nonlytic cellular release of hepatitis A virus requires dual capsid recruitment of the ESCRT-associated Bro1 domain proteins HD-PTP and ALIX.

Shirasaki T. et al, (2022), PLoS pathogens, 18

Structural, Functional and Computational Studies of Membrane Recognition by Plasmodium Perforin-Like Proteins 1 and 2.

Williams SI. et al, (2022), Journal of molecular biology, 434

SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection.

Wei J. et al, (2022), Nat Commun, 13

The C-terminal LCAR of host ANP32 proteins interacts with the influenza A virus nucleoprotein to promote the replication of the viral RNA genome

Wang F. et al, (2022), Nucleic Acids Research, 50, 5713 - 5725

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.

Tuekprakhon A. et al, (2022), Cell

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?